pocketful logo
Vimta Labs Ltd logo

Vimta Labs Ltd

NSE: VIMTALABS BSE: 524394

₹449.80

(-0.73%)

Thu, 21 May 2026, 03:45 pm

mtf coin illustrationMTF 5x

Vimta Labs Share Price Live Chart

1 Day

(-0.73%)

No Result Found

Summary

  • Market Cap

    2137.65

  • Net Profit

    41.01

  • P/B

    3.08

  • Sector P/E

    61.48

  • P/E

    24.03

  • EV/EBITDA

    10.78

  • Debt/Equity (Industry)

    0.62

  • Interest Cover (Industry)

    3303

  • ROCE (Industry)

    0.01

  • RONW (Industry)

    0.01

  • ROE

    13.64

  • ROCE

    16.99

  • Debt/Equity

    0.06

  • EPS (TTM)

    13.61

  • Dividend Yield

    0.21

  • Book Value

    76.74

  • Interest Cover

    26.70

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are covered by earnings (1.6x coverage).
  • Vimta Labs's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Vimta Labs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Vimta Labs is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Vimta Labs's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • The level of debt compared to net worth has increased over the past 5 years (2.9% vs 13.4% today).
  • High level of physical assets or inventory.
  • The average tenure for the Vimta Labs board of directors is less than 3 years, this suggests a new board.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters35.8535.9035.9936.6736.70
FII4.894.594.333.493.66
DII0.140.110.871.421.43
Public59.1259.4158.8058.4258.20
Government00000

Read More

Technical Analysis

RSI

44.61

MACD

-1.33

50 DMA

448.90

200 DMA

579.88

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic642.48544.38500.77446.28402.67348.18250.08
Fibonacci544.38506.91483.76446.28408.81385.66348.18
Camarilla484.13475.13466.14446.28448.16439.16430.17

Pivots Level: Classic

R3

+196.20

642.48

R2

+98.10

544.38

R1

+54.48

500.77

446.28
446.28
Pivot Point
LTP: 450.30

S1

-43.62

402.67

S2

-98.10

348.18

S3

-196.20

250.08

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    459.86

  • 20-EMA

    463.37

  • 30-EMA

    462.38

  • 50-EMA

    464.39

  • 100-EMA

    488.05

  • 200-EMA

    513.87

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
06 May 2026dividend₹2.00 Dividend /Share18 Jun 2026
06 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
28 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results
09 Jun 2025bonus1:1 Bonus Issue of Equity Shares13 Jun 2025
15 May 2025agm
13 May 2025bonusBonus issue 1:113 Jun 2025
30 Apr 2025dividendDividend - Rs. - 230 May 2025
28 Apr 2025dividend₹2.00 Dividend /Share30 May 2025
11 Jun 2024dividendAnnual General Meeting/Dividend - Rs 2 Per Share12 Jul 2024

Read More

Peer Comparison

Vimta Labs Ltd logo

Vimta Labs Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Vimta Labs Ltd About

Vimta Labs provides multi-disciplinary contract research and testing services in India in the areas of clinical research, pre-clinical (animal) studies, clinical reference lab services, environmental assessments and analytical testing of a wide variety of products.

Industry

Miscellaneous

Founded

1990

Headquarters

CEO

S P Vasireddi

Employees

Contact

Website icon

Website

http://www.vimta.com

Email icon

Email

shares@vimta.com

Phone icon

Phone

91-40-27264141

Location icon

Location

Plot No 141/2 & 142, IDA Phase II Cherlapally, Hyderabad, Telangana, 500051

Read More

Vimta Labs Ltd Company History

YearHistory
2011
  • The Board recommended a dividend of Rs. 0.40/- per equity share of Rs. 2/- each.
2013
  • The Board recommended a dividend of 0.60 paise per face value of Rs. 2/- each share.
2014
  • The Board recommended a dividend of Rs. 2 per face value of Rs. 2/- each share.
2020
  • Vimta Labs completed the acquisition of shares of M/s Emtac Laboratories Private Limited.
2024
  • Vimta Labs Limited amalgamated with its wholly owned subsidiary Emtac Laboratories Private Limited.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDbulkSell294330755.6825 Sept 2025
HRTI PRIVATE LIMITEDbulkBuy295059753.5725 Sept 2025
HRTI PRIVATE LIMITEDbulkBuy376745821.3119 Sept 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell248631821.919 Sept 2025
SPDR PORTFOLIO EMERGING MARKETS ETFbulkBuy346373824.0519 Sept 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy248631821.3219 Sept 2025
HRTI PRIVATE LIMITEDbulkSell393620822.8119 Sept 2025
HRTI PRIVATE LIMITEDbulkSell252556806.1811 Sept 2025
HRTI PRIVATE LIMITEDbulkBuy260682799.6211 Sept 2025
HRTI PRIVATE LIMITEDbulkBuy230421826.4409 Sept 2025

Read More

Vimta Labs Ltd News

Vimta Labs Q4 FY26: Revenue Up 16.6%, EBITDA at 37.6%

Vimta Labs Q4 FY26 total income rose 16.6% YoY to INR1,120 million; EBITDA up 21.5% to INR421 million; FY26 PAT grew 16.1% to INR775 million; biologics vertical set for FY27 launch.

13 May 2026

companies

Vimta Labs Q4 FY26 Earnings Call Transcript Released

Vimta Labs releases Q4 FY26 earnings call transcript; total income rose 16.6% YoY to INR1,120 million, EBITDA up 21.5% YoY, PAT grew 15.6% YoY to INR775 million for FY26.

12 May 2026

companies

Vimta Labs Q4 FY26: PAT Up 15.2%, US Subsidiary Planned

Vimta Labs posts Q4 FY26 PAT of ₹211.13 Mn (+15.2% YoY), revenue ₹1,092.45 Mn; board approves US subsidiary incorporation, recommends ₹2/share dividend, and schedules 36th AGM for June 25, 2026.

07 May 2026

companies

Vimta Labs Posts Strong Q4 FY26 Results; Recommends ₹2 Dividend

Vimta Labs reports Q4 FY26 PAT of ₹211 Mn (+15.2% YoY), revenue ₹1,092 Mn, EBITDA ₹421 Mn (+21.5% YoY); board recommends ₹2/share dividend for FY26.

07 May 2026

companies

Vimta Labs Re-appoints Dr. S. P. Vasireddi as Executive Chairman

Vimta Labs' Board recommends re-appointment of Dr. S. P. Vasireddi as Executive Chairman for a five-year term from July 1, 2026 to June 30, 2031, subject to shareholder approval.

07 May 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon
Asset Management Companiesfooter arrow down icon
Popular Stocksfooter arrow down icon
Indian Indicesfooter arrow down icon
Sector Wise Stocksfooter arrow down icon
IPOfooter arrow down icon
Share Marketfooter arrow down icon
Best MF Schemesfooter arrow down icon
Platformsfooter arrow down icon
Resourcesfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800